STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] Biohaven Ltd. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Biohaven Ltd. received a Schedule 13G from Janus Henderson Group plc reporting beneficial ownership of 6,772,113 shares of common stock, representing 6.4% of the class as of the event date 09/30/2025. The filer reports 0 sole voting and dispositive power and 6,772,113 shared voting and dispositive power.

The filing also states that JHIUS may be deemed the beneficial owner of 6,634,902 shares, or 6.3%, with shared voting and dispositive power and no sole power. The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

Positive
  • None.
Negative
  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



JANUS HENDERSON GROUP PLC
Signature:Kristin Mariani
Name/Title:Head of North America Compliance, CCO
Date:11/14/2025
Exhibit Information

POWER OF ATTORNEY The undersigned, Janus Henderson Group plc ("the Company"), does hereby make, constitute and appoint each of Kristin Mariani and Caroline Barotti acting severally, as its true and lawful attorneys in-fact, for the purpose of, from time to time, executing in its name and on its behalf, whether the Company individually or as representative of others, any and all documents, certificates, instruments, statements, other filings and amendments to the foregoing (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including, without limitation, Forms 13D, 13F, 13G and 13H and any amendments to any of the foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental, regulatory authority or other person, and giving and granting to each such attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 9th day of December, 2022. Janus Henderson Group plc By: /s/ Michelle Rosenberg Name: Michelle Rosenberg Title: General Counsel and Company Secretary

FAQ

What did Janus Henderson disclose about BHVN?

Janus Henderson Group plc reported beneficial ownership of 6,772,113 shares of Biohaven common stock, equal to 6.4% of the class.

What is the event date for this BHVN Schedule 13G?

The event date is 09/30/2025.

What voting and dispositive powers were reported?

Sole voting power: 0; Shared voting power: 6,772,113. Sole dispositive power: 0; Shared dispositive power: 6,772,113.

How many BHVN shares does JHIUS report and what percent?

JHIUS may be deemed to beneficially own 6,634,902 shares, representing 6.3%, with shared voting and dispositive power.

Does the filing indicate a passive investment intent?

Yes. It certifies the securities were acquired and are held in the ordinary course of business and not to change or influence control.

Which subsidiaries are identified in relation to the BHVN holdings?

The filing identifies JHIUS, JHIUKL, and JHIAIFML as indirect subsidiaries that furnish investment advice to managed portfolios.
Biohaven

NYSE:BHVN

BHVN Rankings

BHVN Latest News

BHVN Latest SEC Filings

BHVN Stock Data

855.31M
93.58M
11.55%
82.71%
10.06%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN